USP11: A key regulator of cIAP2 stability and sensitivity to SMAC mimetics

Eun-Woo Lee1, Jaewhan Song1

  • 1Department of Biochemistry; College of Life Science and Biotechnology; Yonsei University ; Seoul, Korea.

Insights

Cellular inhibitor of apoptosis proteins (cIAPs) protect cancer cells. A new pathway shows cIAP2, stabilized by USP11, makes cells resistant to SMAC mimetics, impacting cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Research

Background:

  • Cellular inhibitor of apoptosis proteins (cIAPs) are crucial for cancer cell survival against apoptosis.
  • Second mitochondria-derived activator of caspases (SMAC) mimetics were developed to target cIAPs.
  • Cancer cells can develop resistance to apoptosis-inducing therapies.

Purpose of the Study:

  • To investigate a novel survival pathway involving cIAP2 and USP11.
  • To understand the mechanism of resistance to SMAC mimetics.
  • To identify potential therapeutic targets for overcoming cancer cell resistance.

Main Methods:

  • Analysis of tumor necrosis factor-alpha (TNF-α) induced pathways.
  • Investigation of cIAP2 stabilization by its deubiquitylase USP11.
  • Assessment of cellular response to SMAC mimetics in the presence of the novel pathway.

Main Results:

  • Tumor necrosis factor-alpha (TNF-α) induces cIAP2 expression.
  • The deubiquitylase USP11 stabilizes cIAP2.
  • This cIAP2 stabilization confers resistance to SMAC mimetics in cancer cells.

Conclusions:

  • A novel cIAP2-USP11 survival pathway contributes to cancer cell resistance.
  • Targeting this pathway may overcome resistance to SMAC mimetics.
  • Understanding this mechanism is vital for developing effective cancer treatments.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.9K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.4K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
14.5K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.5K